Finario Blog

Capex Confidential: Pharma & Biotech

INSIDER PERSPECTIVES FOR CAPITAL INVESTMENT STAKEHOLDERS Regulatory scrutiny. Scientific breakthroughs. Market saturation in once-lucrative therapeutic areas. Few industries experience change at the velocity pharma and biotech do, and in 2026,

Read More »

New Research Every Capex Stakeholder Needs to See

UPCOMING Webinar

Where and How Enterprise Capex Must Come of Age in 2027 and Beyond

November 19, 2026  •  11:00AM ET